
Efficacy and Safety of Apremilast in Patients With Moderate to Severe Plaque Psoriasis of the Scalp: Results of a Phase 3, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study
Author(s) -
Abby Van Voorhees,
Linda Stein Gold,
Mark Lebwohl,
et al
Publication year - 2019
Publication title -
skin
Language(s) - English
Resource type - Journals
ISSN - 2574-1624
DOI - 10.25251/skin.3.2.10
Subject(s) - medicine , placebo , apremilast , double blind , scalp , multicenter study , psoriasis , randomized controlled trial , dermatology , adverse effect , alternative medicine , pathology , psoriatic arthritis
not available. Disclosures: Study sponsored by Celgene.